Introduction
Almost 900 genes of the human genome encode several thousands of G-protein coupled receptors (GPCRs). GPCRs thus represent the largest family of receptors. The heterotrimeric guanine nucleotide-binding proteins (G-proteins) function to transduce signals from these receptors to effector systems including enzymes, such as adenylyl cyclase and phospholipase C and ion channels. Binding of an agonist to a GPCR induces conformational changes in the receptor protein that enable the receptor to promote guanosine diphosphate (GDP) release from the a-subunit of interacting heterotrimeric G-proteins (Ga) (Wess, 1997) and formation of a high-affinity complex with guanine nucleotide-free Ga (Kent et al., 1980) . The Ga subunit dissociates from the agonist-receptor-Ga complex upon binding of GTP and releases free Ga with bound GTP and bg dimer, both of which are involved in regulation of the activity of various effector systems.
The biological activity of an agonist is a product of both affinity and efficacy. While affinity of an agonist for a receptor is strictly given by free binding energy, agonist efficacy in transducing a signal across the cell membrane depends on time-ordered complex conformational changes involving interactions among agonist, receptor, G-protein and guanine nucleotides. These interactions and the resulting conformational changes are less well characterized. In their pioneering work, De reported that GDP did not affect the efficacy of b-adrenoceptor agonists at G s G-proteincoupled receptors. However, it has been repeatedly demonstrated that GDP affects binding of agonists at Gi G-protein coupled GPCRs (Florio and Sternweis, 1989; Tota and Schimerlik, 1990) , muscarinic agonists decrease GDP binding (Haga et al., 1986; Shiozaki and Haga, 1992) and accelerate its dissociation (Ferguson et al., 1986) . Although the structural basis for many steps in the G-protein nucleotide cycle have been clarified over the past decade, the precise mechanism for receptor-mediated G-protein activation (GDP-GTP exchange) remains incompletely defined largely because of difficulties in obtaining crystals of receptor G-protein complexes for X-ray diffraction analysis (Johnston and Siderovski, 2007; Oldham and Hamm, 2008) .
The aim of our study was to investigate in detail the mechanisms that determine efficacy of agonists at individual classes of G-proteins coupled to M2 muscarinic acetylcholine receptors in natural membrane environments. We performed detailed analyses of allosteric interactions between guanine nucleotides and four structurally distinct agonists exhibiting different potencies and efficacies at the M2 receptor expressed in Chinese hamster ovary (CHO) cells. We showed that the efficacy of these agonists in stimulation of GTP binding correlates with the magnitude of negative cooperativity with GDP binding to the receptor G-protein complex. These data suggest that the decrease in GDP affinity due to acceleration of its dissociation plays a key role in determining agonist efficacy at the muscarinic M2 receptor. We suggest that measurements of GDP binding provide additional information on receptor activation to that obtained from GTP binding assays. Most importantly, it reveals differences in the action of agonists and inverse agonists that are not observable in GTP binding studies.
Methods

Cell culture and membrane preparation
Chinese hamster ovary cells stably transfected with the human M2 muscarinic receptor gene (CHO-M2 cells) were kindly donated by Professor T.I.Bonner. Cell cultures and crude membranes were prepared as described previously (Jakubík et al., 2006) . Briefly, cells were grown to confluency in 75 cm 2 flasks in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 2 ¥ 10 6 cells were subcultured to 100 mm Petri dishes. Medium was supplemented with 5 mM butyrate for the last 24 h of cultivation to increase receptor expression. Cells were detached by mild trypsinization on day 5 after subculture. Detached cells were washed twice in 50 mL of phosphate-buffered saline and 3 min centrifugation at 250¥ g. Washed cells were suspended in 20 mL of ice-cold incubation medium (100 mM NaCl, 20 mM Na-HEPES, 10 mM MgCl2; pH = 7.4) supplemented with 10 mM EDTA and homogenized on ice by two 30 s strokes using Polytron homogenizer (Ultra-Turrax; Janke & Kunkel GmbH & Co. KG, IKA-Labortechnik, Staufen, Germany) with a 30 s pause between strokes. Cell homogenates were centrifuged for 30 min at 30 000¥ g. Supernatants were discarded, pellets resuspended in fresh incubation medium and centrifuged again. Resulting membrane pellets were kept at -20°C until assayed within a maximum of 10 weeks.
Preparation of GDP-less membranes
Membrane-bound GDP was removed by mild denaturation (Ferguson et al., 1986) . Membranes were incubated for 3 h in 1 M ammonium sulphate at 4°C, centrifuged and resuspended in incubation medium containing 20% glycerol for 1 h to allow renaturation. Then they were again centrifuged, resuspended in incubation medium, and used for experiments.
Equilibrium radioligand binding experiments
All radioligand binding experiments were optimized and carried out as described earlier (Jakubík et al., 2006) . Briefly, membranes were incubated in 96-well plates at 30°C in the incubation medium described above that was supplemented with freshly prepared dithiotreitol at a final concentration of 1 mM. (DeLapp et al., 1999) essentially as described earlier (Jakubík et al., 2006) . Association of 500 nM [ 3 H]GDP was measured after 20 min pre-incubation of GDP-less membranes with buffer or carbachol. Dissociation of [ 3 H]GDP was started by addition of 50 mM GDP alone or in mixture with carbachol after prelabelling GDP-less membranes with 500 nM [ 3 H]GDP for 180 min at 30°C. Dissociation was stopped by cooling and solubilization of samples by adding Nonidet P-40 to final concentration of 1% for 15 min. Primary polyclonal rabbit IgG antibody against a subunit of Gi/o or Gs/olf G-proteins in final dilution 1:1000 was then added and samples were incubated on ice for 60 min. Afterwards, 50 mL aliquots of anti-rabbit IgG coated scintillation beads were added (Amersham Bioscience, Buckinghamshire, UK; 500 mg of beads was resuspended in 40 mL of incubation buffer) and incubation continued for another 3 h. Trapped a subunits were pelleted at 4°C and 1500¥ g for 15 min and counted using SPA protocol in Wallac Microbeta scintillation counter.
Data analysis
In general binding data were analysed as described previously (Jakubík et al., 2006) . Data were preprocessed by Open Office 2.3 (http://www.openoffice.org) and subsequently analysed by Grace 5.1.18 (http://plasma-gate.weizman.ac.il/Grace) and statistic package R (http://www.r-project.org) on Mandriva distribution of Linux.
The following equations were fitted to data: Saturation of radioligand binding (Cheng and Prusoff, 1973) . Rate of association 
Allosteric interaction of radioligand
Allosteric interaction between a radioligand and an allosteric modulator was analysed according to the ternary complex model (Ehlert, 1988) .
y, binding of radioligand in the presence of ligand A at concentration x normalized to the absence of ligand A; [D] concentration of radioligand; KD, equilibrium dissociation constant of radioligand; KA; equilibrium dissociation constant of ligand A; a, factor of cooperativity between radioligand and ligand A. Table 1 ). Carbachol and furmethide induced similar maximal increase of [ 35 S]GTPgS binding (threefold and 3.1-fold increase respectively) with half-effective concentrations (EC50) of 12.3 and 7.0 mM respectively. Oxotremorine and pilocarpine were more potent (EC50 = 1.0 and 1.2 mM respectively) but less efficacious (Emax = 2.8 and 1.6-fold increase respectively). The rank order of efficacy was: furmethide = carbachol > oxotremorine > pilocarpine, with a ranking of potency of: oxotremorine = pilocarpine > furmethide = carbachol. Carbachol had no effect on [
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35 S]GTPgS binding at wild-type (non-transfected) CHO cells.
Influence of guanine nucleotides on the affinity of agonists
Affinity of agonist binding was assessed indirectly in competition experiments with 1 nM of the muscarinic radioligand [ 3 H]NMS (Figure 2 ). Competition curves were biphasic and displayed a similar proportion (50 to 66%) of low-affinity binding sites for all agonists but different affinities for both high-and low-affinity binding sites (Table 2) . High-affinity binding ranged from 12 nM for oxotremorine to 120 nM for carbachol and low-affinity binding from 580 nM for oxotremorine to 9 mM for carbachol. Competition curves between [
3 H]NMS and agonists in the presence of 1 mM GTPgS expectedly became monophasic for all agonists ( Figure 2 ) with calculated equilibrium inhibition constants (KI) corresponding to the low-affinity KI in the absence of GTPgS. Similarly, 50 mM GDP present during competition measurements ( Figure 2 ) also converted curves to monophasic ones with KI corresponding to that in the presence of GTPgS and the low-affinity KI in the absence of added nucleotides ( Figure 2 , Table 2 ).
In order to explore the effects of added GDP on agonist binding, we reduced membrane-bound native GDP by inducing its dissociation under slightly denaturing conditions, washing and renaturing as described in Methods. Competition curves remained biphasic (Figure 2 ) but the proportion of low-affinity sites decreased fivefold to sevenfold compared with membranes before treatment ( Table 2) . Low-affinity KI of agonists corresponded to the low-affinity KI under control conditions. High-affinity KI values were significantly lower for carbachol and oxotremorine (twofold and fourfold respectively) and not changed for oxotremorine and pilocarpine.
Characterization of GDP-depleted membranes
In comparison with crude membranes, depletion of GDP did not change the affinity for out of which 18 Ϯ 1 pmol was to Gi/o, 3.5 Ϯ 0.5 pmol to Gq/11 and 4.6 Ϯ 0.6 pmol to Gs/olf G-proteins respectively (means Ϯ SEM, n = 3).
Kinetics of [ 35 S]GTPgS binding to membranes
Measurements of 1 nM [ 35 S]GTPgS binding kinetics were carried out on GDP-depleted membranes without (Figure 3 , left) or with added 50 mM GDP (Figure 3, right) . As shown in Table 3 , addition of GDP slowed down the rate of association 3.2-fold, decreased equilibrium binding 4.7-fold, but did not change the rate of dissociation (Figure 3 , Table 3 ). A saturating concentration of carbachol (100 mM) did not change kinetics of [
35 S]GTPgS binding in the absence of GDP (Figure 3 , left, open circles). In the presence of GDP, carbachol had no effect on the rate of dissociation of [
35 S]GTPgS but accelerated the rate of association 2.6-fold and increased equilibrium binding fourfold (to 92 and 90% of that in the absence of GDP respectively). In the presence of GDP, the inverse agonist NMS slowed the association of [ 35 S]GTPgS by 25% and, similarly to carbachol, did not change dissociation kinetics (Table 3 ).
Kinetics of [ 3 H]GDP binding to membranes
Measurements of 500 nM [ 3 H]GDP binding kinetics ( Figure 4 ) were carried out on GDP-less membranes in the absence or in the presence of 10 mM or 100 mM carbachol or 0.1 mM NMS. Association of [ 3 H]GDP was biphasic with an observed association rate (kobs slow) of 0.010 min -1 for 44% of sites and kobs fast of 0.063 min -1 for the rest. Ten mM carbachol decelerated association of the slower fraction sevenfold while it slowed down that at the faster fraction by only twofold. Carbachol (100 mM) brought further slowing down of both the slower and faster fractions to 0.00024 min -1 and 0. 12 Ϯ 4** 9.6 Ϯ 3.8** 13 Ϯ 4** 7.9 Ϯ 3.2** Equilibrium inhibition constants KI and percentages of low affinity sites were obtained by fitting Equations 3 and 4 to data from individual experiments shown in Figure 2 . KI values of agonists are expressed as negative logarithms of molar concentration (pKi). flow is the fraction of receptors in the low-affinity state. Data are means Ϯ SEM of values from three independent experiments performed in quadruplicates. *P < 0.05; **P < 0.01, significantly different from corresponding control membranes by t-test. GDP, guanosine diphosphate. Constants were obtained by fitting Equations 5a or 6a as appropriate to data from individual experiments shown in Figure 3 . kobs, association rate constant; Beq, binding at equilibrium; koff, dissociation rate constant. Data are means Ϯ SEM of values from three independent experiments performed in quadruplicates.*P < 0.01; significantly different from control (GDP vs. GDP-less, with vs. without carbachol) and a P < 0.05; significantly different from control without ligand by t-test. GDP, guanosine diphosphate; GTPgS, guanosine-5′-g-thiotriphosphate; NMS, N-methylscopolamine.
reduced threefold and fourfold at 10 and 100 mM carbachol, respectively.
Allosteric interactions between GDP and agonists
Carbachol-induced changes in GDP kinetics confirmed allosteric interactions between GDP and carbachol. In order to quantify allosteric interactions between GDP and agonists, their affinities to free receptor-G-protein complex had to be known. Affinity of GDP was determined in equilibrium binding of between GDP and full agonist (carbachol, furmethide) binding. The magnitude of negative cooperativity between agonists and GDP in these experiments was derived from a decrease in displacement of [ 3 H]NMS binding by a fixed concentration of tested agonist by increasing concentrations of GDP in GDP-less membranes. In the absence of agonist, GDP had no effect on [ 3 H]NMS binding ( Figure 7 ). Eqn 7 could not be fitted to the data and the factor of cooperativity a between [ 3 H]NMS and GDP is thus equal to 1. Agonists competed with [ 3 H]NMS and diminished its binding (Figure 7) . GDP allosterically reduced the affinity for agonists that was manifested as an increase in [ 3 H]NMS binding. Factors of cooperativity b between GDP and agonists were calculated by fitting Eqn 8 to the data shown in Figure 7 . GDP diminished the affinity of the full agonists furmethide and carbachol 250-fold and 200-fold, respectively, while the affinity of the partial agonists oxotremorine and pilocarpine was reduced only 60-fold and 25-fold respectively. Estimated affinity for GDP was 3.2 mM (pKA = -5.49 Ϯ 0.03; mean Ϯ SEM.; n = 12) for all fits.
Agonist stimulation of [ 35 S]GTPgS binding to individual G-proteins
Binding of [
35 S]GTPgS to individual subclasses of G-proteins was measured in SPAs ( Figure 8) . As expected, all tested agonists stimulated binding of [ 35 S]GTPgS to Gi/o G-proteins with higher potency than to Gs/olf and Gq/11 G-proteins (Table 4) . The rank order of potencies was oxotremorine = pilocarpine > furmethide > carbachol at all tested G-protein subclasses 35 S]GTPgS binding varied among G-protein classes and was as follows: furmethide = carbachol = oxotremorine > pilocarpine at Gi/o, carbachol = furmethide > oxotremorine > pilocarpine at Gs/olf, and carbachol > furmethide > pilocarpine > oxotremorine at Gq/11.
Kinetics of [ 3 H]GDP binding to individual subclasses of G-proteins
Kinetics of 500 nM [ 3 H]GDP binding at individual subclasses of G-proteins measured in SPA is shown in Figure 9 .
Association of [
3 H]GDP with the Gi/o subclass of G-proteins that preferentially couple with the M2 receptors was biphasic ( Figure 9 , top left) with twice as many sites with fast (kobs1 = 0.055 min -1 ) as with slow (kobs = 0.011 min -1 ) association kinetics (Table 5) . Carbachol converted the association curve to become monophasic and decreased equilibrium binding 1.8-fold and ninefold at 10 and 100 mM concentrations respectively. Carbachol (100 mM) slowed down the association of [ 3 H]GDP 12-fold in comparison to fast sites or 10-fold in comparison to mono-exponential fit of association data under control conditions (in the absence of carbachol) (kobs = 0.042 Ϯ 0.005 min -1 ; Beq = 2.8 Ϯ 0.3 fmol·mg·prot -1 ; mean Ϯ SEM; n = 3). Dissociation curves were biphasic in the absence as well as in the presence of carbachol with 36 to 38% of slow binding sites. Carbachol accelerated the dissociation rate to a similar extent from both slow and fast sites. Acceleration was 6.3-6.5-fold by 10 mM carbachol and eightfold by 100 mM carbachol respectively ( Figure 9 , lower left; Table 5 ).
Muscarinic M2 receptors also couple non-preferentially with the Gs/olf and Gq/11 subclasses of G-proteins. We therefore attempted to determine the influence of carbachol on the kinetics of [ 3 H]GDP binding at these two other major G-protein subclasses. Unlike the results obtained for the Gi/o subclass, association and dissociation curves of [ 3 H]GDP binding with Gs/olf were monophasic in the absence as well as in the presence of carbachol (Figure 9 , right column). Carbachol had no effect on [ 3 H]GDP binding association rate, accelerated [
3 H]GDP dissociation rate 1.8-fold and threefold, and decreased equilibrium binding 1.9-fold and 8.1-fold at 10 and 100 mM carbachol respectively (Figure 9 , top right, Table 5 ). We were not able to determine the kinetics of [ 3 H]GDP binding at Gq/11 subclass of G-proteins due to extremely fast on and off rates.
Allosteric interactions between GDP and agonists at individual subclasses of G-proteins
Effects of agonists on equilibrium binding of 10 mM Figure 1 . Half effective molar concentration of agonists is expressed as negative logarithm (pEC50) and maximal stimulation (EMAX) as fold increase over basal binding. Data are means Ϯ SEM of values from three individual experiments performed in quadruplicates. *P < 0.05, significantly different from carbachol; **P < 0.01, significantly different from carbachol and furmethide; ***P < 0.001, significantly different from all other agonists by ANOVA and Tukey's test. GTPgS, guanosine-5′-g-thiotriphosphate; n.c., no convergence.
G-proteins. Oxotremorine (Figure 10 ), unlike all other agonists, had no effect on [ 3 H]GDP equilibrium binding to Gq/11 (Figure 10 , lower panel) G-proteins. The rank order of factors of cooperativity between [ 3 H]GDP and agonist binding varied among G-protein classes and was as follows: furmethide = carbachol = oxotremorine > pilocarpine at Gi/o, carbachol = furmethide > oxotremorine > pilocarpine at Gs/olf, and carbachol > furmethide > pilocarpine > oxotremorine at Gq/11 (Table 6 ).
Discussion
Conventional determination of agonist efficacy of G-protein coupled receptors often utilizes measurements of agonistinduced activation of GTPgS binding. We analysed the role of GDP (the second guanine nucleotide that binds to G-proteins) in the process of activation of the M2 muscarinic acetylcholine receptors and tested whether changes in its binding could serve as a possible measure of agonist efficacy. The muscarinic agonists studied here differ in structure as well as affinity and efficacy to stimulate GTPgS binding via the M2 muscarinic receptor (Figure 1 ). Binding studies show that GTPgS decreases the affinity of agonists as reported previously for the majority of, if not all, GPCRs (Wess, 1997) . The decrease in agonist affinity is generally interpreted as being due to disintegration of the receptor/G-protein complex and the liberation of the signalling GTPgS-liganded G-protein a-subunit and complex of bg subunits (Johnston and Siderovski, 2007) . In accordance with previous findings (Haga et al., 1986; Florio and Sternweis, 1989; Tota and Schimerlik, 1990; Shiozaki and Haga, 1992) our data demonstrate that at the muscarinic M2 receptors GDP also decreases agonist affinity. In addition, we found that reduction of membrane-bound GDP increases the proportion of high-affinity binding sites for all agonists to a similar extent (Figure 2 ). Adding GDP back to GDP-less membranes reduces agonist affinity (Figure 7 ). These findings are consistent with the existence of an agonist low-affinity conformation of the receptor that is complexed with GDP-liganded G-protein, in addition to the agonist low-affinity conformation of receptor that is uncoupled from G-protein upon binding of GTP (Abdulaev et al., 2006) .
Although the affinity of agonists at the low-affinity binding state is similar in the presence of either GDP or GTPgS, kinetics of guanine nucleotides binding provide evidence that the molecular mechanisms of modulation of agonist affinity is different. The ability of carbachol to accelerate dissociation and decelerate association of GDP (Figure 4) proves the existence of allosteric interaction between agonist and GDP on the receptor/G-protein complex. On the other hand, the inability of agonists to change the kinetics of GTPgS binding in the absence of GDP ( Figure 3 , left column; Table 3 ) is in concert with data obtained in a reconstituted system (Florio and Sternweis, 1989) and the commonly accepted concept that the GTPgSliganded Ga subunit dissociates from receptor (Johnston and Siderovski, 2007) and therefore the kinetics of GTPgS binding cannot be allosterically regulated by agonists. Receptormediated acceleration of GTPgS association in the presence of GDP ( Figure 3 , upper row; Table 3 ) is a consequence of accelerated GDP dissociation, while in the absence of GDP the speed of GTPgS binding (irrespective of presence or absence of agonist) is already maximal. Lack of effect of agonists on the rate of GTPgS dissociation in both the presence and absence of GDP ( Figure 3 , lower row; Table 3) notion that, under our experimental conditions, the Ga subunit with bound GTPgS is not in physical contact with the receptor.
Agonist-induced allosteric acceleration of GDP dissociation from the Ga subunit strongly implies involvement of this mechanism in regulating the strength (efficacy) of agonist signal transmission to intracellular second messenger pathways. Despite multiple lines of evidence for allosteric interaction between agonist and GDP on receptor-Gprotein complex the magnitude of these allosteric interactions has not been quantified so far. Our present data show that the magnitude of negative cooperativity between the four tested agonists displaying different potencies and efficacies, and GDP binding (Figure 6 ) demonstrate that full agonists (carbachol, furmethide) display significantly stronger negative cooperativity than partial agonists (oxotremorine, pilocarpine). The magnitude of negative cooperativity correlates with agonist efficacy in stimulating GTPgS binding to membranes (furmethide Ն carbachol > oxotremorine > pilocarpine) (Figure 11 ). Interestingly, 30 years ago Birdsall et al. (1978) showed that agonist efficacy correlates with the ratio of agonist high-and low-affinity binding. Our results confirm these observations and provide a plausible interpretation. Agonist high-affinity binding takes place at a receptor-G-protein complex free of GDP and low-affinity binding occurs at a complex with GDP-liganded G-protein that is low due to negative cooperativity in binding of agonist and GDP. The stronger the negative cooperativity (more negative pa in our experiments) is, the higher the agonist efficacy and the lower the agonist affinity is in the low-affinity binding state. Thus, agonist efficacy correlates with the difference in affinities of the agonist high and low-affinity binding states.
In addition to inhibition of adenylyl cyclase (G imediated), activation of non-preferential G-proteins is associated with strong stimulation of adenylyl cyclase and Figure 10 . Data are means Ϯ SEM of values from three independent experiments performed in quadruplicates. GDP, guanosine diphosphate.
relatively weak effects on accumulation of inositol phosphates (Gq-medited) by muscarinic M2 receptors was observed repeatedly (Ashkenazi et al., 1987; Burford et al., 1995; Jakubík et al., 1996; Michal et al., 2001; . In SPAs, furmethide, carbachol and pilocarpine stimulated GTPgS binding to preferential Gi/o as well as non-preferential Gs/olf and Gq/11 G-proteins. In contrast, oxotremorine stimulated GTPgS binding only to Gi/o and Gs/olf G-proteins (Figure 8 , Table 4 ). Different orders of efficacies at individual G-protein classes can be explained by the concept of agonist specific conformations (Kenakin, 2003) , where individual agonists induce different receptor conformations that differ in the ability to activate individual classes of G-proteins.
In agreement with an allosteric mode of action, affinities of GDP for the Ga subunits calculated from interactions with all of the tested agonists are the same (between 2.9 and 3.4 mM; Figures 6, 7 and 10) and correspond well to published values (Thomas et al., 1993) as well as results of [ 3 H]GDP kinetics (Figures 4 and 9 ; Tables 3 and 5) and [ 3 H]GDP saturation binding ( Figure 5 ). Thus, changes in GDP affinity or kinetics are good measures of agonist efficacy at the Gi/ocoupled M2 muscarinic receptor. In practice, being the first step next to receptor activation, [
3 H]GDP binding appears to be a more direct measure of receptor activation than GTPgS binding or second messenger levels in case of M2 receptors, and this may be so at other Gi/o coupled GPCRs. However, this assay requires laborious preparation of membranes free of GDP. Agonist induced changes in GTPgS binding were demonstrated in fused Gsa/b2-adrenoceptors where agonist efficacy was well reflected by changes in the kinetics of GTPgS binding (Wenzel-Seifert and Seifert, 2000; Seifert et al., 2001) . and Gs/olf (bottom right) subclasses of G-proteins was measured by scintillation proximity assay as described in Methods. GDP-less membranes were pre-incubated for 20 min with either buffer or 10 mM or 100 mM carbachol. Then, 500 nM [ 3 H]GDP was added and association terminated by filtration at the indicated times (abscissa, min). [ 3 H]GDP binding (ordinate) is expressed as fmol per mg of protein. In dissociation measurements, GDP-less membranes were equilibrated for two hours in the presence of 500 nM [ 3 H]GDP. Dissociation was then initiated by the addition of 50 mM GDP alone or in combination with carbachol at 10 mM or 100 mM and terminated at indicated times (abscissa, min). [ 3 H]GDP binding (ordinate) is expressed as per cent of binding at the beginning of dissociation. Data are expressed as mean Ϯ SEM of values from three experiments performed in triplicate. Curves were fitted using Equations 5a and 5b (association) or 6a and 6b (dissociation). Results of fits are shown in Table 5 .
However, in concert with the involvement of agonistinduced decrease in GDP affinity in G-protein activation, GDP differentially and concentration-dependently influenced relative efficacies of partial agonists in increasing GTPgS binding (Wenzel-Seifert and Seifert, 2000) . In accordance with previous findings (Florio and Sternweis, 1989) , agonists at M2 receptors under our experimental conditions do not change the kinetics of GTPgS binding in the absence of GDP (Figure 3) . Thus, while a change in the kinetic of GTPgS binding is a good measure of activation of physically coupled G-protein/b2-adrenoceptors, kinetics of GDP binding seem to be a closer measure in case of M2 muscarinic receptors and likely in other GPCR. Another drawback of GTPgS binding measurements is their dependence on the concentration of GDP that strongly affects outcome of the experiments (Figure 3) . Also, unlike GDP binding, GTPgS concentrationresponse curve has to be measured under non-equilibrium conditions (Figure 3) .
The data presented here show some interesting aspects of the process of receptor activation. NMS was reported as an inverse agonist at the M2 receptor (Jakubík et al., 1995; Burstein et al., 1997) and behaved as inverse agonist under our experimental conditions (Figures 1 and 8) . Although positive cooperativity in binding with GDP would be expected, our data show that the cooperativity between NMS and GDP is neutral (Figures 6 and 7) and NMS only slightly slows down GDP dissociation (Figure 4 right) , implying different mechanisms underlying the inverse agonist nature of NMS. One possible explanation may be that NMS stabilizes the receptor in the ground state (inactive conformation) (Hulme et al., 2003) that leads to reduction of spontaneous transition of the ligand-free receptor to an active state and slower rate of GDP 
Figure 10
Allosteric interactions between agonists and [ 3 H]GDP at individual G-proteins. The magnitude of allosteric interactions between agonists (carbachol, furmethide, oxotremorine, pilocarpine) and [ 3 H]GDP was measured directly as changes in equilibrium binding of 10 mM [ 3 H]GDP to Gi/o (upper left), Gs/olf (upper right) or Gq/11 (lower row) G-proteins in the presence of increasing ligand concentration (abscissa, log M) via scintillation proximity assay as described in Methods. Data are presented as mean Ϯ SEM of values from three experiments performed in quadruplicate. Curves were fitted using Equation 7. Results of fits are shown in the Table 6. dissociation. Significantly, this difference in mechanisms of agonism and inverse agonism cannot be revealed by measurement of GTPgS binding.
The second interesting aspect of our study is derived from data shown in Figure 9 that illustrates that carbachol slows down association of GDP with Gi/o G-proteins but does not change the rate of association of GDP with Gs/olf G-proteins. These data suggest that interaction of the M2 receptor with preferential Gi/o G-proteins differs from that with nonpreferential Gs/olf G-proteins. One possible explanation is that Gi/o G-proteins precouple to M2 receptors while Gs/olf do not (Shea and Linderman, 1997; Hein et al., 2005) , where precoupling gives an agonist a chance to influence GDP association while collision coupling does not. However, demonstration of this difference in coupling requires further detailed analysis. Again, this difference in kinetics at Gi/o and Gs/olf classes of G-proteins cannot be revealed by measurement of GTPgS binding.
In conclusion, we have demonstrated that the negative cooperativity between GDP and agonist binding played a key role in signal transduction via the M2 receptor. Agonistinduced low-affinity conformation of the Ga G-protein subunit for GDP leads to accelerated dissociation of bound GDP that in turn accelerates binding of GTP and G-protein activation. Thus, stronger negative cooperativity between a given agonist and GDP binding leads to a bigger shift of the GDP/GTP affinity ratio resulting in a higher rate of GTP binding and agonist efficacy. Our data demonstrated benefits of GDP binding measurements that can reveal mechanistic differences that are not apparent in measurements of GTP binding, as was demonstrated in case of inverse agonists versus agonists or G i/o versus Gs/olf G-proteins. Measurements of GDP binding therefore provide additional information beyond that obtained from GTP binding measurements.
-3 -2.5 -2 -1.5 -1 -0.5 0 pα (Tables 1 and 4) are plotted against the negative logarithms of the factor of binding cooperativity between agonist and GDP (pa) (results of Figure 6 and Table 6 ). Lines: 2D (Deming) linear regression of the data.
